Clorox exec vests 8,672 shares; direct holdings 35,667 shares
Rhea-AI Filing Summary
Insider transactions at Clorox Co (CLX): an executive reported multiple equity transactions on 10/03/2025. The reporting person acquired 8,672 shares through settlement of a 2022 performance unit grant at an effective price of $122.25, increasing direct holdings to 35,667 shares. The filing also shows withholding of 1,904 and 3,629 shares to satisfy tax obligations tied to restricted stock and performance stock units, respectively, and 462 shares from dividend reinvestment. Additionally, 612.574 shares are held indirectly via the company 401(k). The form was signed by an attorney-in-fact on 10/07/2025.
Positive
- Settlement of performance units increased direct ownership by 8,672 shares
- Post-transaction direct holdings are 35,667 shares, showing continued executive stake
Negative
- Significant share withholding for taxes (1,904 and 3,629 shares) reduced net share additions
- Majority of acquired shares were from vesting rather than open‑market purchases, limiting positive market signaling
Insights
Settlement of long‑term incentive increased exec ownership without open‑market buying.
The 2022 performance unit grant vested and settled on 10/03/2025, delivering 8,672 shares at an effective value of $122.25 per share. This is a routine compensation event converting deferred equity into stock, raising direct holdings to 35,667 shares.
Withholding of 1,904 and 3,629 shares to cover taxes reduced net share additions; 10/03/2025 activity therefore shows compensation realization rather than discretionary open‑market purchases. Monitor next proxy for updated executive ownership and potential future grants within the next fiscal year.
Insider holdings rose modestly; indirect holdings via benefits plan remain small.
Post‑transaction direct ownership is reported as 35,667 shares, with 612.574 shares held indirectly through the company 401(k). The mix of settlement and tax withholding is typical and does not indicate trading for liquidity or signaling.
Investors may note the form was executed by an attorney‑in‑fact on 10/07/2025. Watch upcoming filings for any scheduled sales or additional vesting dates tied to long‑term incentive schedules.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 8,672 | $122.25 | $1.06M |
| Tax Withholding | Common Stock | 1,904 | $122.25 | $233K |
| Tax Withholding | Common Stock | 3,629 | $122.25 | $444K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Settlement of 2022 Performance Unit Grant, which vested 10/3/25. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units. Includes 462 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Includes shares acquired through 10/3/25, pursuant to the Company's 401(k) plan.
